Fig. 7From: A robust blood gene expression-based prognostic model for castration-resistant prostate cancerSurvival curve of high- and low-risk patients in the first validation set based on Wang_4genescore (a), Ross_6genescore (b) and Olmos_9genescore (c) calculated using RNAseq measurement with predefined cutoffsBack to article page